Anavex Life Sciences is a clinical-stage biopharmaceutical company developing oral therapies for neurodegenerative and neurodevelopmental diseases.
Meet Anavex’s executive leadership and scientific advisors, whose experience in drug development, clinical research, and regulatory science guides the Company’s strategic direction.
Terrie Kellmeyer, PhD, Interim Chief Executive Officer, brings over 28 years of experience in the pharmaceutical industry and has held...
Prof. Dr. Marwan Sabbagh, MD, is a behavioral neurologist in the Alzheimer’s and Memory Disorders Program at Barrow Neurological Institute....
Ms. Ma is a Senior Board executive with over 25 years of experience in investing, building, and scaling companies with...
Claus van der Velden, PhD brings significant expertise in management, accounting, internal controls, information security and risk management. Since May...
Juan Carlos Lopez-Talavera, MD, PhD, brings over 20 years of leadership experience in managing registrational clinical trials and advancing patient...
Dr. Paeger is a seasoned leader in healthcare with over 30 years of experience in running inpatient medical care. Dr....
At Anavex Life Sciences, our work is driven by rigorous research, cross-functional collaboration, and a shared commitment to addressing unmet medical needs. We bring together scientists, clinicians, and professionals across disciplines to support the development of innovative oral therapeutic programs.
We recognize that disease progression and treatment response vary across individuals. Our research and development approach emphasizes precision strategies designed to address underlying biological mechanisms and patient variability.
Patients and caregivers provide essential insight into disease impact and treatment priorities. We value collaboration with patient communities and integrate real-world perspectives into our research and development process.
Our development programs are grounded in translational science and supported by data-driven decision-making across discovery, clinical research, and regulatory pathways.
We are committed to fostering an inclusive workplace and supporting the development of therapies intended to serve diverse patient populations worldwide.
Toll-free: 1 (844) 689-3939
ir@anavex.com
media@anavex.com
